The establishment of a universal blocking ELISA for echinococcosis using immunoglobulin against a new conserved linear B-cell epitope
Microbiology Spectrum·
- DOI
- 10.1128/spectrum.03933-25
- PMID
- —
- PMCID
- —
- OpenAlex
- W7203751440
- Study type
- Journal article
- Publisher
- American Society for Microbiology
- Article type
- journal-article
- Integrity
- current
Why this research matters now
The reported methodology presents a standardized laboratory tool that could assist in routine monitoring and control efforts for echinococcosis in affected livestock populations.
Structured evidence summary
Research question
How can monoclonal antibodies targeting the Em18 protein be utilized to create a reliable serological assay for echinococcosis?
Study design
An in vitro experimental study employing hybridoma technology to generate antibodies, followed by biochemical characterization, epitope mapping, and analytical validation of a newly developed blocking enzyme-linked immunosorbent assay.
Population and setting
Laboratory environment utilizing recombinant proteins, murine ascites, and forty-seven pooled serum specimens obtained from cattle and sheep.
Main findings
Six monoclonal antibodies were successfully produced and shown to bind a highly conserved linear sequence on the Em18 protein. A blocking assay built around one optimized antibody achieved ninety percent sensitivity, maintained stability across dilutions, and aligned closely with a commercial alternative. The technique exhibited strict specificity against unrelated pathogens while demonstrating applicability across varying infection severities and echinococcosis forms.
Public-health relevance
The reported methodology presents a standardized laboratory tool that could assist in routine monitoring and control efforts for echinococcosis in affected livestock populations.
Important limitations
Analytical validation was restricted to a small set of forty-seven animal serum samples, and human clinical performance or longitudinal field reliability was not assessed.
GIDS interpretation
This peer-reviewed article documents the initial development and bench-level validation of a diagnostic reagent, offering a citable reference for researchers tracking advancements in parasitic disease serology.
Related GIDS surveillance
Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.
Evidence relationships
This article has 8 auditable classifier relationships to diseases, places, topics, and study design.